MICTONORM XL 30 MG (PROPIVERINE HYDROCHLORIDE) – MODIFIED-RELEASE CAPSULES

Active Ingredient: Propiverine Hydrochloride 30 mg.

Dosage Form: Modified-release hard capsules.

Route of Administration: Oral.

Therapeutic Class: Urinary Antispasmodic / Antimuscarinic Agent.

ATC Code: G04BD06.

Product Overview

Mictonorm XL contains propiverine hydrochloride, an antimuscarinic medication used to manage symptoms associated with overactive bladder and certain types of urinary bladder dysfunction.

It works by relaxing the smooth muscles of the urinary bladder, reducing involuntary bladder contractions and increasing bladder storage capacity.

The modified-release formulation is designed to release the active ingredient gradually, allowing once-daily administration in adults.

Mictonorm XL helps manage urinary urgency, increased frequency of urination, and urge urinary incontinence, supporting improved bladder control and daily quality of life.

Indications and Therapeutic Uses

Mictonorm XL is used for the symptomatic treatment of urinary bladder dysfunction, particularly:

1. Overactive Bladder (OAB): Helps reduce involuntary bladder contractions and improve bladder storage capacity.
2. Urinary Urgency: Helps reduce sudden, compelling urges to urinate.
3. Urinary Frequency: Helps decrease the need for frequent urination during the day.
4. Urge Urinary Incontinence: Helps reduce involuntary urine leakage associated with overactive bladder.
5. Bladder Instability: Helps manage symptoms associated with involuntary detrusor muscle activity.

Important: The precise approved indications may vary by country and product registration. Mictonorm XL should not be considered a treatment for every cause of urinary incontinence.

Mechanism of Action

Propiverine hydrochloride works through two complementary mechanisms to reduce involuntary urinary bladder contractions:

• Antimuscarinic Activity: Blocks muscarinic receptors in the bladder, reducing acetylcholine-induced detrusor muscle contractions.
• Calcium Channel Modulation: Inhibits calcium influx into bladder smooth muscle cells, producing a direct muscle-relaxing effect.

These actions contribute to:

• Reduced involuntary bladder contractions.
• Increased functional bladder capacity.
• Improved control over urination.
• Reduced urinary urgency and frequency.
• Fewer episodes of urge urinary incontinence.

The modified-release formulation gradually releases propiverine, providing prolonged therapeutic activity throughout the day.

Dosage and Administration

Mictonorm XL 30 mg is administered orally.

Recommended adult dosage:

• The usual recommended dose is one 30 mg capsule once daily.
• It can be taken with or without food.
• Swallow the capsule whole with sufficient water.
• Do not crush, open, or chew the capsule, as this may interfere with its modified-release properties.

Special populations:

• Elderly: Generally, no specific dosage adjustment is required.
• Renal impairment: No dose adjustment is generally required in patients with mild to severe renal impairment according to the referenced product information; clinical monitoring is advised.
• Hepatic impairment: Use cautiously in mild hepatic impairment. Treatment is not recommended in moderate to severe hepatic impairment.
• Children: Not recommended because of insufficient safety and efficacy data.

Important: Treatment should be prescribed and monitored by a healthcare professional.

Possible Side Effects

Mictonorm XL may cause adverse effects, primarily related to its anticholinergic activity.

Very common side effects:

- Dry mouth.

Common side effects:

• Constipation.
• Headache.
• Abdominal pain.
• Indigestion (dyspepsia).
• Blurred vision or difficulty focusing.
• Fatigue.

Uncommon side effects:

• Dizziness.
• Tremors.
• Nausea and vomiting.
• Flushing.
• Reduced blood pressure.
• Itching.
• Urinary retention.

Rare or very rare side effects:

• Hypersensitivity reactions.
• Skin rash.
• Increased heart rate (tachycardia).
• Palpitations.
• Confusion or restlessness.

Important: Seek medical attention if severe urinary retention, significant visual disturbances, or symptoms of an allergic reaction occur.

Contraindications

Mictonorm XL should not be used in patients with:

• Known hypersensitivity to propiverine hydrochloride or any of the product's ingredients.
• Significant bladder outflow obstruction where urinary retention is anticipated.
• Intestinal obstruction.
• Intestinal atony.
• Severe ulcerative colitis.
• Toxic megacolon.
• Myasthenia gravis.
• Uncontrolled angle-closure glaucoma.
• Moderate to severe hepatic impairment.
• Tachyarrhythmias (abnormally rapid heart rhythms).

Warnings and Precautions

• Urinary Retention: Use cautiously in patients with bladder outlet obstruction or difficulty emptying the bladder.
• Prostatic Enlargement: Patients with benign prostatic hyperplasia should be monitored for worsening urinary symptoms.
• Glaucoma: Caution is required in patients predisposed to angle-closure glaucoma.
• Gastrointestinal Disorders: Use cautiously in patients with gastrointestinal motility disorders or gastroesophageal reflux.
• Cardiovascular Conditions: Patients with cardiac arrhythmias, tachycardia, or severe heart failure require careful medical assessment.
• Renal Impairment: Appropriate clinical monitoring is recommended.
• Hepatic Impairment: Use cautiously in mild hepatic impairment and avoid use in moderate to severe impairment.
• Visual Disturbances: Blurred vision or drowsiness may affect driving and operating machinery.
• Lactose Intolerance: Each capsule contains approximately 5.7 mg of lactose monohydrate; patients with rare hereditary galactose intolerance or glucose-galactose malabsorption should consult their physician.

Drug Interactions

Mictonorm XL may interact with several medications:

1. Anticholinergic Drugs: Concomitant use may increase anticholinergic effects, including dry mouth, constipation, and urinary retention.
2. Tricyclic Antidepressants: Medications such as imipramine may increase anticholinergic adverse effects.
3. Benzodiazepines and Tranquilizers: May increase sedative effects.
4. Antipsychotics: Certain medications, including phenothiazines, may increase anticholinergic effects.
5. Amantadine: May increase the risk of anticholinergic adverse reactions.
6. Beta-Adrenergic Agonists: Their effects may be enhanced when administered with propiverine.
7. Cholinergic Medications: May reduce the therapeutic effect of propiverine.
8. Metoclopramide: Propiverine may reduce its gastrointestinal prokinetic effect.
9. CYP3A4 Inhibitors: Certain azole antifungals and macrolide antibiotics may affect propiverine metabolism, particularly in combination with methimazole.

Patients should inform their physician or pharmacist about all medications they are taking before starting treatment.

Storage Conditions

• Store below 30°C.
• Keep in the original packaging to protect from moisture.
• Do not use after the expiry date printed on the package.
• Keep out of reach of children.

Product Presentation

MICTONORM XL 30 MG

1. UK Medicines and Healthcare products Regulatory Agency (MHRA): Official Summary of Product Characteristics for Mictonorm XL 30 mg Modified-Release Capsules. Mictonorm XL 30 mg – Official SmPC.
2. Spanish Agency of Medicines and Medical Devices (AEMPS): Official product information for Mictonorm 30 mg Modified-Release Capsules. AEMPS – Mictonorm 30 mg Product Information.
3. Health Products Regulatory Authority (HPRA), Ireland: Official Summary of Product Characteristics for Detrunorm XL 30 mg, containing the same active ingredient and strength. HPRA – Propiverine 30 mg Modified-Release Capsules.
4. Lebanese Ministry of Public Health: Registered Mictonorm XL 30 mg, 28-capsule presentation. Lebanese Ministry of Public Health – Mictonorm XL.
5. Official Summary of Product Characteristics: Pharmacological properties, contraindications, precautions, adverse reactions, and storage requirements. Mictonorm XL 30 mg – Full Product Information.

Patient Disclaimer

This information is provided for educational purposes only and should not replace professional medical advice, diagnosis, or treatment.

Mictonorm XL is a prescription medication and should only be used under the supervision of a qualified healthcare professional. The recommended dosage and treatment duration should be determined according to the patient's medical condition and individual response.

Patients should not start, discontinue, or modify treatment without consulting their physician or pharmacist.

This product is not intended to diagnose, treat, cure, or prevent any disease without appropriate medical evaluation and supervision.